Anne Marie
Chris Hill spent over a decade as the host of Motley Fool Money, helping millions of investors understand markets with clarity and insight. Now the host of Money Unplugged, Hill has seen countless fads, trends, and boom-bust cycles come and go.
So when a seasoned investor like Chris Hill names three stocks he’d be happy to hold forever, it’s worth paying attention.
In a recent episode of the Stock Club podcast, Hill did just that—naming three companies he’d confidently own for the next 25 years, spanning everything from non-lethal defense tech to a trillion-dollar conglomerate.
1. Axon Enterprise (NASDAQ: AXON)
Formerly known as Taser International, Axon is a $58 billion company best known for its non-lethal weapons and law enforcement technologies.
Hill emphasized that Axon has both growth potential and a mission he wants to support. “It’s a business I want to see succeed,” he said. From body cameras to cloud-based evidence systems, Axon is embedding itself deeper into law enforcement infrastructure globally.
With its recurring revenue model, expanding product suite, and dominant market position, Axon remains a quietly compounding stock in a space with high barriers to entry.
Bonus: Chris is not alone in his conviction. MyWallSt analysts have previously spotlighted Axon, citing long-term tailwinds and product ecosystem strength.
2. Berkshire Hathaway (NYSE: BRK.B)
Buffett may be retiring, but Hill isn’t backing away. In fact, he’s been saying for years that when Buffett steps down, investors will overreact—and that would be his moment to buy more.
True to his word, Hill added shares when Berkshire dropped 5% after the May 2025 announcement. He believes Greg Abel, Buffett’s successor, won’t drastically underperform—and that the business is too strong to ignore.
From GEICO and BNSF Railways to Apple and Coca-Cola holdings, Berkshire’s blend of operating companies and investments makes it one of the most diversified and resilient businesses on the planet.
Want a deeper dive? Read our recent breakdown: Is Berkshire Hathaway a Buy Despite Warren Buffett Retiring?
3. CRISPR Therapeutics (NASDAQ: CRSP)
The wildcard in Hill’s forever portfolio is CRISPR Therapeutics—a $5.5 billion gene-editing company at the frontier of medicine.
He discovered it through a panel at Horizon Live, then bought shares shortly after. Though the stock dipped ~20% post-purchase, he remains confident.
Gene-editing has breakthrough potential, and CRISPR is one of the category leaders. Hill acknowledges the risks—but also the upside. “I’m rooting for the technology,” he said.
With FDA-approved treatments beginning to roll out and new trials underway, CRISPR has the potential to change medicine—and portfolios—for decades.
CRISPR was also named by Chief Investor Emmet Savage as his favorite stock for 2025.
Related Questions Investors Are Asking
What is a good forever stock?
A forever stock is one you can hold for decades without worrying about quarterly volatility—typically companies with strong moats, recurring revenue, and responsible capital allocation.
Are long-term stocks safe?
No stock is 100% safe, but long-term picks often weather downturns better due to business quality, diversified operations, and defensible margins.
Why did Chris Hill choose Axon, Berkshire, and CRISPR?
He selected a mix of proven leadership (Berkshire), mission-driven growth (Axon), and disruptive potential (CRISPR)—creating a portfolio that spans stability and innovation.